Navigation Links
VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)
Date:5/14/2009

ATLANTA, May 14 /PRNewswire/ -- ANY LAB TEST NOW(R), the first retail direct-access lab testing franchise with over 55 locations nationwide, has partnered with Atherotech, Inc., a Birmingham, Alabama-based CLIA-laboratory to provide the VAP(R) Cholesterol Test direct to consumers at an affordable price. The VAP Cholesterol Test is an expanded cholesterol profile that identifies a greater number of people at risk and is the first cholesterol test to directly measure LDL.

ANY LAB TEST NOW continues to revolutionize direct-access lab testing by offering thousands of medical lab tests and Value Panels affordably to consumers and businesses in a convenient retail setting. Each location works with local physicians to provide patients -- specifically self-pay and un-/under-insured -- with a more affordable lab testing alternative. No appointment or insurance is necessary and results are typically given within 24-48 hours.

The comprehensive VAP Cholesterol Test is based on ultracentrifugation, the "gold standard" method of measuring cholesterol. Through this process, the VAP Test gives customers and their doctors comprehensive information on the treatment and management of cardiovascular conditions. The test, which doesn't require fasting, provides direct measurements of LDL, HDL and all relevant subclasses, and includes non-HDL, a highly accurate determination of apoB, and emerging risk factors such as Lp(a), remnants and small dense LDL.

"We are excited to bring the VAP Test directly to consumers at such an attractive price point because it empowers them to manage their own health, gain more insight in their cardiovascular health and provide their health care provider with more information to accurately treat and manage their health," said Joe Neely, chief executive officer of ANY LAB TEST NOW.

"ANY LAB TEST NOW is a good fit for the VAP Test as it allows a growing population more access at an affordable price," said Atherotech, Inc. President Michael Mullen. "Our test gives people an opportunity to mitigate their risks that might have otherwise gone undetected. Any solution to a problem starts with identification and the VAP Test opens more doors for more people to treat potential problems."

As part of the partnership, ANY LAB TEST NOW will offer the VAP Test individually at the low price of $79 and also include it as part of two Value Panels, the Metabolic Syndrome Panel ($229) and the Heart Health Panel ($279). The Metabolic Syndrome Panel also includes a Chemistry Panel with 16 essential tests, Hemoglobin A1c and Insulin. The Hearth Health Panel also includes a Chemistry Panel, C-Reactive Protein (High Sensitivity) and Homocysteine.

For more information about the VAP Test or the partnership, please visit www.anylabtestnow.com/VAP.

About Atherotech, Inc.

Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.thevaptest.com.

About ANY LAB TEST NOW(R)

Founded in 1992, ANY LAB TEST NOW(R) is a franchise lab testing facility that provides thousands of medical lab tests to consumers and employers in a professional, convenient and cost-effective manner without the need of an appointment or insurance. With facilities throughout the U.S., ANY LAB TEST NOW offers a variety of affordable and confidential lab tests to consumers and businesses including general health and wellness panels, pregnancy, HIV/STD, drug, paternity and many more tests. To learn more about ANY LAB TEST NOW, visit www.anylabtestnow.com.


'/>"/>
SOURCE ANY LAB TEST NOW; Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia
2. Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando
3. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
4. VAP(R) Cholesterol Test Helps Researchers Identify Treatment Effects of Combination Therapy
5. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
6. VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured
7. VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment
8. First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch
9. VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
10. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
11. New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... data bioInformatics portal. In response to client demand KbioBox developed a sophisticated “3 ... biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review and ... crops. The authors focus on the economic effects in countries that are major global ... biotech crops and the resultant risk of low level presence (LLP) puts large volumes ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
Breaking Biology Technology:
(Date:12/7/2016)... BioCatch , the global leader in behavioral biometrics, reported a ... over 40 granted and pending patents. ... , The Company,s IP portfolio expansion ... Device, and Method Estimating Force Applied to a Touch Surface, " ... components needed to estimate the force and pressure applied to touch surfaces ...
(Date:12/6/2016)... 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... offering of €500.0 million principal amount of its 1.414% senior ... its 2.425% senior unsecured notes due 2026. ... December 13, 2016, subject to the satisfaction of customary closing conditions.  ... The Company intends to use the ...
(Date:12/5/2016)... 5, 2016  The Office of Justice Programs, ... CT Scans Enhance or Replace Medico Legal Autopsies?" ... supporting or replacing forensic autopsies with postmortem X-ray ... In response to recommendations made by The ... CT scans as a potential component of medicolegal ...
Breaking Biology News(10 mins):